封面
市場調查報告書
商品編碼
1789546

質子治療市場(按安裝類型、適應症和地區分類)

Proton Therapy Market, By Set up Type, By Indication, and By Region

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

質子治療市場在 2025 年的估值為 35.281 億美元,預計到 2032 年將達到 83.02 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 13.0%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 35.281億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年 13.00% 2032年預測 83.2億美元

質子治療是一種放射療法,利用高功率治療癌症和某些非癌性腫瘤。 X 光放射線治療長期以來一直用於治療癌細胞和癌細胞等疾病。質子治療利用帶正電粒子(質子)的能量。它不僅用於治療惡性腫瘤,還用於治療非癌性腫瘤。質子治療應用於治療疾病或與手術或化療等其他治療方法結合使用。當癌症在定期 X 光照射後持續存在或復發時,可以使用質子治療。質子治療有時用於治療多種癌症,包括腦瘤、肉瘤、攝護腺癌、兒童癌症和胰臟癌。這種治療方法可以精確地將高能量輻射遞送到目標癌症或癌細胞。預計癌症研究資金的增加將為市場參與企業提供有利可圖的成長機會。此外,提供質子治療的醫療機構數量不斷增加也有望推動市場成長。

市場動態

主要市場參與企業正專注於採取合作和收購等成長策略,預計將推動全球質子治療市場的成長。癌症患者和醫療機構數量的增加預計將推動市場成長。例如,2022年8月,醫療科技公司Ion Beam Applications (IBA)宣布已與多學科醫療機構Apollo Hospitals Enterprise Ltd (AHEL)簽署合作協議,為IBA在亞洲的客戶提供質子治療培訓和教育計畫。

本次調查的主要特點

  • 本研究報告對全球質子治療市場進行了詳細分析,提供了預測期 2025 年至 2032 年的市場規模(百萬美元)和年複合成長率(CAGR),以 2024 年為基準年。
  • 它揭示了各個領域的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數,對全球質子治療市場的關鍵公司進行了概述。
  • 本研究報告介紹的主要企業包括日立、Ion Beam Applications SA、Mevion Medical Systems、三菱電機株式會社、Provision Healthcare、ProTom International、工業、瓦里安醫療系統、Optivus Proton Therapy, Inc. 和 Advanced Oncotherapy plc。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、成長策略、市場擴張和行銷策略做出明智的決策。
  • 全球質子治療市場報告涉及該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 透過全球質子治療市場分析中使用的各種策略矩陣,相關人員將更容易做出決策。

目錄

第1章:調查目標和先決條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 抑制因素
  • 市場機會
  • 影響分析
  • 最新產品發布
  • 流行病學
  • 合併、收購和合作
  • 監管情景
  • PEST分析

4. 2020 年至 2032 年全球質子治療市場(依安裝類型)

  • 介紹
  • 單人房
  • 多間客房

5. 全球質子治療市場(依適應症分類),2020 年至 2032 年

  • 介紹
  • 頭頸癌
  • 肉瘤
  • 兒童癌症
  • 胃腸道癌症
  • 攝護腺癌
  • 肺癌

6. 2020 年至 2032 年全球質子治療市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 東南亞國協
    • 其他亞太地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東地區
  • 非洲
    • 南非
    • 中部非洲
    • 北非

第7章 競爭態勢

  • 公司簡介
    • Hitachi Ltd.
    • Ion Beam Applications SA
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • Provision Healthcare
    • Protom International
    • Sumitomo Heavy Industries Ltd.
    • Varian Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • Advanced Oncotherapy plc.

第 8 章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI3672

Proton Therapy Market is estimated to be valued at USD 3,528.1 Mn in 2025 and is expected to reach USD 8,300.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,528.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.00% 2032 Value Projection: USD 8,300.2 Mn

Proton therapy is a type of radiation therapy that uses high-power energy to treat cancer and certain non-cancerous tumors. Radiation therapy using X-rays has long been used to treat the conditions such as tumor cell or cancer cells. Proton therapy uses energy from positively charged particles (protons). It is used to treat non-cancerous tumors as well as malignancy. Proton therapy must be used to treat the illness, or it must be combined with other treatments like surgery and chemotherapy. If the cancer is still present or returns after conventional X-ray radiation, proton treatment may also be employed. Proton therapy is sometimes used to treat various cancers such as brain tumors, sarcoma, prostate cancer, pediatric cancer, and pancreatic cancer. The therapy utilizes a precision dose of high-energy radiation in the target cancer cells and tumor cells. Increasing funding for cancer research is expected to offer lucrative growth opportunities for market players. Furthermore, the increasing number of healthcare facilities offering proton therapy is also expected to drive market growth.

Market Dynamics

The key market players are focused on adopting growth strategies, such as collaboration and acquisitions, which is anticipated to fuel the global proton therapy market growth. The increasing number of cancer patients and healthcare facilities is expected to boost the market growth. For instance, in August 2022, IBA (Ion Beam Applications), a medical technology company, announced that it had signed a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL), a multispecialty health care unit, to provide proton therapy training and education programs for IBA customers in Asia.

Key features of the study

  • This report provides an in-depth analysis of the global proton therapy market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global proton therapy market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, Provision Healthcare, ProTom International, Sumitomo Heavy Industries, Varian Medical Systems, Optivus Proton Therapy, Inc., and Advanced Oncotherapy plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global proton therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proton therapy market.

Market Segmentation

  • Global Proton Therapy Market, By Set-up Type
    • Single Room
    • Multiple Room
  • Global Proton Therapy Market, By Indication
    • Head & Neck Cancer
    • Sarcoma
    • Pediatric Cancer
    • Gastro-intestinal Cancer
    • Prostate Cancer
    • Lung Cancer
  • Global Proton Therapy Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Hitachi Ltd.
    • Ion Beam Applications SA
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • Provision Healthcare
    • Protom International
    • Sumitomo Heavy Industries
    • Varian Medical Systems
    • Optivus Proton Therapy, Inc.
    • Advanced Oncotherapy plc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Setup Type
    • Market Snippet, By Indication
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis

4. Global Proton Therapy Market, By Set up Type, 2020-2032 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Single Room
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Multiple Room
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Proton Therapy Market, By Indication, 2020-2032 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Head & Neck Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Sarcoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pediatric Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Gastro-intestinal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Proton Therapy Market, By Region, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region 2021-2032
  • North America
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020-2032, (USD Mn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Company Profiles
    • Hitachi Ltd.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ion Beam Applications SA
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mevion Medical Systems
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mitsubishi Electric Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Provision Healthcare
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Protom International
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Sumitomo Heavy Industries Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Varian Medical Systems, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Optivus Proton Therapy, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Advanced Oncotherapy plc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact